BDMD vs. KRMD, CVRX, AVR, LNSR, RCEL, LUCD, PDEX, INFU, PTHL, and LAKE
Should you be buying Baird Medical Investment stock or one of its competitors? The main competitors of Baird Medical Investment include KORU Medical Systems (KRMD), CVRx (CVRX), Anteris Technologies Global (AVR), LENSAR (LNSR), Avita Medical (RCEL), Lucid Diagnostics (LUCD), Pro-Dex (PDEX), InfuSystem (INFU), Pheton (PTHL), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry.
Baird Medical Investment vs. Its Competitors
Baird Medical Investment (NASDAQ:BDMD) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.
KORU Medical Systems has a consensus target price of $4.50, suggesting a potential upside of 24.31%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Baird Medical Investment.
Baird Medical Investment has higher earnings, but lower revenue than KORU Medical Systems.
In the previous week, KORU Medical Systems had 1 more articles in the media than Baird Medical Investment. MarketBeat recorded 2 mentions for KORU Medical Systems and 1 mentions for Baird Medical Investment. KORU Medical Systems' average media sentiment score of 0.84 beat Baird Medical Investment's score of -0.63 indicating that KORU Medical Systems is being referred to more favorably in the news media.
Baird Medical Investment has a net margin of 0.00% compared to KORU Medical Systems' net margin of -15.09%. Baird Medical Investment's return on equity of 0.00% beat KORU Medical Systems' return on equity.
Baird Medical Investment has a beta of -0.94, suggesting that its share price is 194% less volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.52, suggesting that its share price is 48% less volatile than the S&P 500.
19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Comparatively, 20.6% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Summary
KORU Medical Systems beats Baird Medical Investment on 9 of the 13 factors compared between the two stocks.
Get Baird Medical Investment News Delivered to You Automatically
Sign up to receive the latest news and ratings for BDMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Baird Medical Investment Competitors List
Related Companies and Tools
This page (NASDAQ:BDMD) was last updated on 7/3/2025 by MarketBeat.com Staff
